Abstract
Optically active propargylic alcohols serve as an important building block in asymmetric synthesis. The customised synthesis of chiral ligands and transition metal activators as catalysts, to effect asymmetric alkynylation reactions, continue to feature in the literature. This review article focuses upon the use of Zn(OTf)2, in conjunction with 2-point chiral ligands, for effecting asymmetric alkynylation reactions to aldehydes.
Current Organic Chemistry
Title: Asymmetric Alkynylation Reactions of Aldehydes Using a Zn(OTf)2-Chiral Ligand-Base System
Volume: 13 Issue: 15
Author(s): Elizabeth Tyrrell
Affiliation:
Abstract: Optically active propargylic alcohols serve as an important building block in asymmetric synthesis. The customised synthesis of chiral ligands and transition metal activators as catalysts, to effect asymmetric alkynylation reactions, continue to feature in the literature. This review article focuses upon the use of Zn(OTf)2, in conjunction with 2-point chiral ligands, for effecting asymmetric alkynylation reactions to aldehydes.
Export Options
About this article
Cite this article as:
Tyrrell Elizabeth, Asymmetric Alkynylation Reactions of Aldehydes Using a Zn(OTf)2-Chiral Ligand-Base System, Current Organic Chemistry 2009; 13 (15) . https://dx.doi.org/10.2174/138527209789177716
DOI https://dx.doi.org/10.2174/138527209789177716 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Is It the Twilight of BACE1 Inhibitors?
Current Neuropharmacology Protein/Polyphenol Interactions: Past and Present Contributions. Mechanisms of Astringency Perception
Current Organic Chemistry Cannabinoids and Neuroprotection in Motor-Related Disorders
CNS & Neurological Disorders - Drug Targets A Comparative Review of Rodent Prefrontal Cortex and Working Memory
Current Molecular Medicine Interactions of Cnidarian Toxins with the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Differentiating the Dementias. Revisiting Synucleinopathies and Tauopathies
Current Alzheimer Research Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Electro-Acupuncture Protects Diabetic Nephropathy-Induced Inflammation Through Suppression of NLRP3 Inflammasome in Renal Macrophage Isolation
Endocrine, Metabolic & Immune Disorders - Drug Targets Coronary CT and the Coronary Calcium Score, the Future of ED Risk Stratification?
Current Cardiology Reviews Meningioma in an Elderly Presenting as Psychosis: A Case Report
Clinical Cancer Drugs Nanomedicine for Intranasal Delivery to Improve Brain Uptake
Current Drug Delivery Cytoprotection by Melatonin, Precursors and Metabolites in an In Vitro Model of Neurotoxicity Induced by Okadaic Acid
Letters in Drug Design & Discovery The Applications of Pharmacogenomics to Neurological Disorders
Current Molecular Medicine Meet Our Co-Editor
Cardiovascular & Hematological Agents in Medicinal Chemistry BOOK REVIEW : New Frontiers in Mirror Neurons Research
Current Aging Science Agonists at the a4b2 Nicotinic Acetylcholine Receptors Relationships and Molecular Modelling
Current Medicinal Chemistry Progress in the Development of Nonpeptidomimetic BACE 1 Inhibitors for Alzheimers Disease
Current Medicinal Chemistry Inhibition of Neurofibrillary Degeneration: A Promising Approach to Alzheimers Disease and Other Tauopathies
Current Drug Targets Modulation of Cardiovascular Remodeling with Statins: Fact or Fiction?
Current Vascular Pharmacology